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ABSTRACT
Stem cell based therapies for the repair and regeneration of various tissues are of great 
interest for a high number of diseases. Adult stem cells, instead, are more available, abundant and 
harvested with minimally invasive procedures. In particular, mesenchymal stem cells (MSCs) are 
multipotent progenitors, able to differentiate into bone, cartilage and adipose tissues. Human adult 
adipose tissue seems to be the most abundant source of MSCs and, due to its easy accessibility; it is 
able to give a considerable amount of stem cells. In this study, we selected mesenchymal stem cells 
co-expressing CD34 and CD90 from adipose tissue. This stem cell population displayed higher 
proliferative capacity than CD34
-
CD90
-
 cells and was  able to differentiate in vitro into adipocytes 
(PPAR?+ and adiponectin+) and endothelial cells (CD31+VEGF+Flk1+). In addition, in 
methylcellulose without VEGF,  it  formed a vascular network.   
The aim of this study was to investigate differentiation potential of human adipose CD34
+
/CD90
+
stem cells loaded onto commercial collagen sponges already used in clinical practice (Gingistat) 
both in vitro and in vivo. 
The results of this study clearly demonstrate that human adult adipose and loose connective 
tissues can be obtained in vivo, highlighting that CD34+/CD90 ASCs are extremely useful for 
regenerative medicine. 
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INTRODUCTION
Recently, the role of stem cells in tissue formation and regenerative medicine attracted 
considerable attention as a possible source of differentiated cells. In addition, the use of stem cells 
with biomaterial scaffolds and growth factors represents a suitable strategy for clinical therapies. 
Stem cells are undifferentiated cells characterized by their ability to self-renew and to 
differentiate into multiple lineages (Zech et al., 2011). In contrast to embryonic stem cells (ESCs), 
adult stem cells are immune-compatible and there are no ethical issues related to their use (Brignier 
and Gewirtz, 2010). Initially, adult stem cells from bone marrow (BM-MSCs) have been studied as 
an alternative source (Wang et al., 2011; Conget and Minguell, 1999). These cells can differentiate 
into adipocytes, chondrocytes, osteoblasts, myoblasts and neurons, among others (Schilling et al.,
2007; Ferrari et al., 1998; Woodbury et al., 2000). However, the clinical use of BM-MSCs 
presented several problems, including pain, morbidity, and low cell number upon harvest. 
Therefore, many researchers investigated alternative sources of MSCs in different tissues such as 
dental pulp (Graziano et al., 2008), Wharton jelly (Romanov et al., 2003), amniotic fluid 
(Roubelakis et al., 2011) and adipose tissue (Zuk et al., 2002). 
Adipose tissue derived from mesenchyme represents an optimal source of adult stem cells, 
sharing many characteristics with bone marrow, including extensive proliferation and ability to 
undergo multi-lineage differentiation (Witkowska-Zimmy and Walenko, 2011). It contains 
numerous cells types, including adipocytes, preadipocytes, and vascular endothelial cells. In our 
previous experiments, using human liposuction or lipectomy, we have identified a stem cell 
population that expressed MSCs markers, including CD34, CD90, CD29, CD44, and CD105, but 
they do not express the hematopoietic marker CD45. Cloning studies have shown that this cells 
have multi-lineage differentiation potential (Zuk et al., 2001; Halvorsen et al., 2001; Erickson et al.,
2002). Moreover, we have demonstrated that CD34
+
/CD90
+
 stem cell population is capable of: i) 
differentiating into endothelial cells and forming capillary-like structures in a semisolid medium 
with or without the use of angiogenic factors; ii) forming sphere clusters in a serum-free medium 
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supplemented with bFGF and EGF; iii) showing higher telomerase activity than differentiated cells 
and iv) displaying a side population phenotype (De Francesco et al., 2009). The combination of 
these properties, and the large quantity of cells that can be obtained from fat, suggest that this tissue 
will be a useful tool in biotechnology and regenerative medicine. 
Currently, plastic surgeon uses autologous tissue grafts, including dermal and fat grafting, 
free and pedicle flap or synthetic implants for the reconstruction and/or augmentation of soft tissue 
(Ferraro et al., 2011; Rosson et al., 2010). Various levels of clinical success have been reported 
with the use of autologous soft tissue. However, donor-site morbidity remains the principal liability. 
In addition, autologous tissue grafts have a tendency to lose volume with an average of 40 to 60 % 
reduction in tissue volume gradually. Engineered soft tissue from stem cells has the potential to 
overtake most of lack associated with autologous soft-tissue grafts (Stosich and Mao, 2005). 
Biodegradable scaffolds should ideally provide the initial required blood flow, and then gradually 
degrade to leave a graft composed only of new tissue. Researchers have developed several studies 
of adipose tissue engineering by using BM-MSCs and ASCs. Various scaffold materials have been 
analyzed both in vitro and in vivo, using synthetic or natural prefabricated scaffolds such as 
poly(lactic-co-glycolic acid) (Morgan et al., 2009), poly(ethylene glycol)-based hydrogel (Stosich 
and Mao, 2005), silk fibroin scaffold (Mauney et al., 2007), hyaluronic acid (Hemmrich et al.,
2008) and collagen (von Heimburg et al., 2001; von Heimburg et al., 2003), but, up to now, 
obtained data are still not suitable for clinical application.
The ideal scaffold must have certain characteristics: i) easy to shape it in the tissue defect; ii) 
good capacity of growing and maturating stem cells; and iii) reabsorption time compatible with the 
time required for tissue formation. 
Type I collagen, the main fibre of the extra-cellular matrix in connective tissues, has shown 
a high affinity for the living organism and has also been extensively used as scaffold for adipose 
tissue engineering (Rubin et al., 2007; Itoi et al., 2010). 
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Therefore, the aim of this study was to evaluate the distribution in vitro of cultured 
CD34
+
CD90
+
 ASCs into commercial solid collagen sponges, and study the differentiation potential 
in vivo of the grafted ASCs loaded on these scaffolds.
MATERIALS AND METHODS 
In vitro tissue culture
Subcutaneous adipose tissue from abdomen and mammary region was obtained with 
informed consent, approved by our Internal Ethical Committee (Second University Ethical 
Committee) from 52 female donors aged 18 to 43 years (mean years 30,5) that had endured elective 
procedures for plastic surgery. Adipose tissue was obtained by lipectomy or liposuction in the 
Plastic and Reconstructive Surgery Clinic of the Second University of Naples. The adipose tissue 
was placed in a physiological solution (0.9% NaCl), washed twice in PBS (phosphate saline buffer: 
137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4), scraped, and placed in a digestion 
solution: collagenase type I (3mg/ml) and dispase (4mg/ml) in PBS at  37°C in agitation for 60 min. 
The digestive solution was filtered through 70 µm filters (Becton & Dickinson, Sunnyvale, CA). 
After filtration and washing, the pellet was re-suspended in erythrocyte lysis buffer (155mM 
NH4Cl, 10mM KHCO3, 0.1mM EDTA, pH 7.3) for 10 min at room temperature. The cell 
suspension was centrifuged at 1300 rpm for 7 min and the pellet re-suspended in 5ml Dulbecco's 
modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS), 2mM L-glutamine, 
100U/ml penicillin, and 100µg/ml streptomycin and seeded in 25cm
2
flasks. Flasks were incubated 
at 37 °C under 5% CO2 and the medium changed twice a week. Cells reached confluence in 5-7 
days. Experiments were performed in quadruplicate.
Cells were detached using trypsin-EDTA (200mg/L EDTA, 500mg/L trypsin; Cambrex). At least 
200,000 cells were incubated with primary antibody for 30 min at 4°C, washed twice in PBS, and 
incubated with a secondary antibody. Alternatively, cells were incubated directly with fluorescent-
conjugated antibodies for 30min at 4°C, washed, and re-suspended in 0.6ml PBS. Samples were 
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analyzed at day 0 (day of surgery), day 7, day 15, and day 30 by flow cytometry using a FACS Aria 
II (Becton & Dickinson, Mountain View, CA,USA). The antibodies used in this study were: anti-
CD117 PE (c-kit) (Miltenyi–Biotech, Calderara di Reno, Bologna, Italy); anti-CD34 FITC and PE 
(Miltenyi-Biotech); anti-CD90 FITC (BD Pharmingen, Buccinasco, Milano, Italy); anti-CD105 
FITC (Santa Cruz, CA, USA); anti-CD29 PE (Miltenyi-Biotech); anti-CD31 FITC (Miltenyi-
Biotech); anti-CD133 PE (Miltenyi-Biotech); anti-hVEGF (Santa Cruz, CA); anti-VEGFR-2 (Santa 
Cruz); anti-CD54 PE (Miltenyi-Biotech); anti-CD44 FITC (Miltenyi-Biotech), anti-CD45 Cy and 
PE (BD Pharmingen, Buccinasco, Milano, Italy); and anti-CD14 PE (Miltenyi-Biotech). 
CD34
+
/CD90
+
 cells were sorted for experiments. The purity of sorted populations was routinely of 
90%.
Growth Curve 
 CD34
+
CD90
+
, CD34
-
CD90
-
 and unsorted cells were plated at a density of 8,0×10
4
 cells/well 
in 6-well plates. Every twelve hours, cells were harvested and re-suspended in PBS for 7 days. An 
aliquot of cell suspension was counted under a microscope at 20 X magnification. The number of 
viable cells for each experimental condition was counted and represented on a linear graph. The 
doubling time (DT) was determined from the growth curves or by using the formula: 
DT = (t–t0)log2/(logN–logN0)
where t and t0 were the times at which the cells were counted, and N and N0 were the cell numbers 
at times t and t0, respectively.
In vitro adipogenic differentiation of ASCs 
Cells were induced in the following adipogenic medium for 2-3 weeks: DMEM 
supplemented with 10% FBS plus dexamethasone (1?M; Sigma), human recombinant insulin (10 
?M; Sigma), indomethacin (200 ?M; Fluka,) and 3-isobutyl-1-methyl-xantine (IBMX) (0.5 mM; 
Sigma). Cells cultured in basal medium (see above) were used as controls. 
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In vitro angiogenic differentiation of ASCs 
To analyze in vitro capillary-like morphology, 2 x 10
5
 - 5 x 10
5
 cells/ml were plated in 24-
well plates in a semisolid growth medium that consisted of 0.9% methylcellulose in DMEM, 30% 
FBS, 1% bovine serum albumin (BSA), 10
-4
mol/L mercaptoethanol, and 2 mmol/L L-glutammine. 
In parallel experiments, cultures were stimulated in addition with Vascular Endothelial Growth 
Factor (VEGF, 50 ng/ml). All cultures were performed in triplicate, incubated at 37° C under 5% 
CO2 and left for 7 days to develop a capillary-like morphology. 
Preparation of collagen sponges for in vitro analyses and in vivo transplantation 
After trypsinisation with 0.05% trypsin-EDTA, either unsorted ASCs or ASCs 
CD34
+
/CD90
+
, at a density of 2x10
5
 cells/injection were seeded onto Collagen sponge of 10x10 
mm size and cultured in DMEM at 10% FBS. Gingistat (GabaVebas, San Giuliano Milanese, Italy) 
used in this study, is a commercial type 1 collagen, made of native lyophilized collagen from animal 
origin (equine) with interconnected pores with an average size of 300µm.Collagen sponges were cut 
in 10x10mm squared pieces and then sterilized under UV exposure.  These constructs were 
incubated for 48h at 37 °C to allow the cells to attach to the scaffolds. For in vitro examinations of 
cell adherence and proliferation on carriers, sponges were analyses after 7 and 14 days, and 
histologically evaluated. Cell viability was routinely checked by Calcein AM at the concentration of 
250?M in culture medium for 30 min at 37°C. This dye passes through the cell membrane of viable 
cells. After calcein permeates into the cytoplasm, it is hydrolyzed by esterases to calcein, which 
remains inside the cell. The excitation and emission wavelengths of calcein were of 490 nm and 515 
nm, respectively. For in vivo studies, the construct was left undisturbed in DMEM in the incubator 
for 48h until implantation.
In vivo experimental model for grafting 
For in vivo experiments, we have used ASCs of subcutaneous adipose tissue from abdomen 
and breast of 2 healthy female donors (mean years 30) with a normal range of BMI. We have 
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previously obtained informed consent, approved by our Internal Ethical Committee (Second 
University Ethical Committee).  
Twenty-four hours after seeding of the cells to the scaffold, unsorted ASCs and 
CD34
+
/CD90
+
 ASCs (at a density of 2×10
5
 cells/injection)/sponge matrix constructs were engrafted 
subcutaneously to the right and left scapular area of 4-week-old immune-compromised athymic 
nude mice (NU/NU nude mice, Charles River, Ballina, Italy) according to the scheme reported in 
Table 1. Mice were operated under aseptic conditions and inhalation anesthesia. In each of these 
animals, the cell-loaded sample was transplanted to the right and the control scaffold to the left 
scapular area through separate incisions. After 4 weeks, the animals were killed by an overdose of 
gaseous anesthetic and the graft was explanted. The experimental protocols have been evaluated 
and approved by our Internal Animal Ethic Committee (Second University Animal Ethic 
Committee). Explanted tissue volume was calculated by the formula ( l x w2 )/2. The injection 
experiments were made in triplicates. 
Haematoxylin & Eosin and Mallory’s Trichromic Staining 
Constructs derived from implantations in mice were fixed with 4% paraformaldehyde for 24 
hours at 4°C, washed in PBS, incubated in 30% sucrose for 3 days, washed in PBS and then 
embedded in an optimal cutting temperature (OCT-purchased from Bio-Optica, Milan, Italy). 
Finally, they were stored at -80°C for Mallory’s trichromic and hematoxylin and eosin (H&E) 
staining. The frozen sections in the OCT were cut into 5?m thick slices, washed in distiller water 
for 10 min. For haematoxylin and eosin staining, sections were placed in haematoxylin for 5 
minutes. After three washes by distilled water, samples were placed in spring water for 20 min. 
Then, the samples were placed in eosin acidified with acetic acid for 30 seconds. Finally, they were 
placed in alcohol 95°, 75° and 95° and mounted with DPX. For Mallory’s trichromic stain, the 
sections were stained in acid fuchsine for 1 min, methylene blue-orange G and oxalic acid solution 
for 25 min, and phosphotungstic acid for 15 min; fibrils of collagen are blue, nuclei red, and 
cytoplasm is orange. Finally, they were placed in alcohols 95°, 75° and 95° and mounted with DPX.  
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Immunofluorescence and Immunohistochemistry 
Frozen sections in OCT were cut into 5 ?m thick slices, washed in distiller water for 10 min. 
For immunofluorescence, tissue sections were incubated in PBS at 5% milk for 60 min at room 
temperature. After a double washing in PBS for 10 min at room temperature, cells were incubated 
overnight at 4°C with monoclonal anti-human antibodies (diluted 1:100 in PBS). Sections were 
washed in PBS three times for 10 min at room temperature and incubated for 90 min at 4°C with the 
secondary FITC- or PE-conjugated antibody (diluted 1:200 in PBS) (AbCam, Cambridge, UK). 
Moreover, sections were stained with DAPI (4', 6-diamidino-2-phenylindole) (Invitrogen, San 
Giuliano Milanese, Milan, Italy) diluted 1:10000 (5?g/ml) in PBS for 7 min at room temperature. 
Tissue sections incubated for 90 min at 4°C only with conjugated secondary antibodies were used 
as negative control. The sections were then observed under a fluorescence microscope (Nikon 
Instruments Italia, Calenzano, Firenze, Italy). Immunohistochemical analyses were performed with 
a DAKO CYTOMATION kit (En Vision+System-HRP-AEC, Dako Italia, Milan, Italy). Antibodies 
used were: I Class HLA (AbCam), anti-adiponectin (AbCam) , Glut4 (AbCam), PPAR? (AbCam), 
Collagen Type I (AbCam) and VEGF (AbCam). 
RNA isolation and polymerase chain reaction 
Frozen tissues were homogenized in TRIzol® lysis buffer using a handheld homogenizer for 
at least 45 seconds. Then, the samples were centrifuged at 12,000 x g for 10 minutes at 4°C. The 
supernatant was processed for the phase separation in according with the manufacturer’s 
instructions. RNA concentration and purity were determined by A260 and A260/A280 ratios, 
respectively. The integrity of total RNA was assessed on standard 1% agarose/formaldehyde gels. 
The RNA samples were treated with DNase I to remove residual traces of DNA. cDNA was 
obtained from 1?g of total RNA, using reverse transcriptase (Promega Italia srl, Milan, Italy) and 
random primers (Promega) in a final volume of 20?l. cDNAs (1?l for each sample) were amplified 
by PCR using the primer sequences as follows: 
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GADPH: fw5’-AGCCGCATCTTCTTTTGCGTC-3’,rw5’-TCATATTTGGCAGGTTTTTCT-
3’;
humanadiponectin: fw 5’-CAACATTCCTGGGCTGTACT-3’, rw 5’-
CCTGTGAAGGTGGAGTCATT-3’;
human PPAR-?: fw 5’-ACAGCAAACCCCTATTCCATGC-3’, rw: 5’-
ATTACGGAGAGATCCACGGAGC-3’;
humanVEGF: fw5’-TGACAGGGAAGAGGAGGAGA-3’,rw5’-
CGTCTGACCTGGGGTAGAGA-3’;
humanfibronectin: fw5'-CTGGGATGCTCCTGCTGTCAC-3', rw 5'-
CTGTTTGATCTGGACCTGCAG-3';
human collagen type I:fw 5’-TACCATGACCGAGACGTGTG-3’, rw 5’-
ATAAGACAGCTGGGGAGCAA-3’.
The RT-PCR products were separated by 2% agarose gel electrophoresis, stained with 
ethidium bromide, and photographed under UV illumination. 
Statistical analysis 
Student t-test (two tailed) was used for statistical evaluation. Level of significance was set at 
p<0.05.
RESULTS
In vitro experiments
In vitro characterization of ASCs
Adipose tissue was obtained by lipectomy or liposuction. After enzymatic digestion, 
samples of 1,000,000 cells were collected from cell suspension and cultured. After three days of 
culture, adherent cells acquired a fibroblast-like or polygonal shape morphology. Cells were 
analysed by flow-cytometry at different times. At day 0, as previously demonstrated by us (De 
Francesco et al., 2009), we detected stromal cells co-expressing CD117 (~5%) and CD34 (~7%), 
mesenchymal stem cells, co-expressing CD29 (?1-integrin) (~72%), CD34 (~25%), CD90 (Thy-1) 
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(~30%), and CD105 (endoglin) (~5%) and endothelial stem cells, co-expressing CD31 (~6%), 
CD133 (~8%), CD44
+
CD54
+
(~5%) and Flk-1 (VEGFR-2) (~45%) (Fig. 1A,B). Only CD34
+
CD90
+
cells (~25%) were sorted (Fig. 1C) and cultured for both in vitro and in vivo experiments. Co-
expression of CD34 and CD90 markers was ~53% and ~80%, at 7 and 15 days (Fig. 1D), 
respectively while after 30 days, their expression was ~8%. CD90 expression was 80% (Fig. 1E). 
CD34
+
CD90
+
 cells exhibited: i. a higher proliferative capacity than CD34
+
CD90
+
 cells with a mean 
doubling time of 72 hours with respect to 86 and 100 hours of unsorted cells and CD34
-
CD90
-
 cells, 
respectively (Fig. 2); ii. In adipogenic medium, some unsorted cells acquired the morphology of 
fibroblasts, whereas other acquired the morphology of multi-vacuolar adipocytes (Fig. 3A), positive 
for adiponectin, (Fig. 3B). On the contrary, CD34
+
CD90
+
 cells acquired the typical morphology of 
adipocytes (Fig. 3C) positive, for adiponectin and PPAR-? already after 24h of incubation at the 
immunohistochemistry (Fig. 3D,E); iii. In methylcellulose without VEGF, they formed a vascular 
network (Fig. 3F) while in standard medium, they acquired an endothelial morphology and 
expressed high levels of endothelial markers such as CD90 (~97%), CD44 (~90%), CD54 (~90%), 
VEGF (~70%), CD133 (~18%), and Flk-1 (~60%) (Fig. 3G). 
Cell attachment to the scaffold and in vitro observations 
Each scaffold was loaded with 2x10
5
 sorted ASCs (CD34
+
CD90
+
), placed in the incubator 
for 48 h and analyzed afterwards for cell attachment. The range of unattached CD34
+
CD90
+
cells
was approximately 5% in all sponges, as well as for unsorted cells. Adherence and viability of 
CD34
+
CD90
+
ASCs to sponges was high, as shown by Calcein staining (Fig. 4A,B). In order to 
evaluate cell proliferation, constructs were analyzed by light-inverted microscopy (Fig. 4C,D) and 
by histological staining after 7 and 14 days (Fig. 4E,F). Light-inverted microscopy and H&E 
staining on serial sections of ASCs seeded onto the Gingistat collagen sponge demonstrated that the 
cells were homogeneously distributed throughout the whole sponge. Moreover, at day 14, a strong 
spreading and the proliferation of ASCs was observed with respect to day 7. 
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In vivo experiments
In vivo adipose tissue and loose connective formation 
Unsorted ASCs or ASCs CD34
+
/CD90
+
, at a density of 2x10
5
 cells/injection were seeded 
onto Collagen sponge of 10x10 mm size (Fig. 5A). After 30 days of implantation, we extracted the 
constructs sorted ASCs/collagen from athymic nude mice (Fig. 5B,C) (mean tissue volume 125,94 
± 1 mm
3
), unsorted ASCs/collagen (mean tissue volume 119.52 ± 0.8 mm
3
) (Table 2). Collagen 
without cells used as controls, was not detectable on the dorsum of mice because it has been 
completely reabsorbed (Fig. 5D) as well as unsorted and sorted ASCs. The grafts with unsorted 
ASCs showed formation of adipose tissue appearing almost avascular (Fig. 6A). All collagen 
sponges with ASCs CD34
+
CD90
+
 showed a thin layer of macroscopically yellow tissue and new 
vessels on the top. This layer was tightly connected to the sponge.
H&E staining showed that, within the sorted ASCs/collagen constructs, stem cells 
differentiated towards adipocytes (fig. 6B). Neo-formed adipose tissue was made of fat cells 
arranged into groups or lobules separated by collagenic septa. Moreover, each individual fat cell 
was surrounded by a network of loose connective tissue (Fig. 6C). The formation of this connective 
tissue surrounding the adipose tissue was observed in all histological serial slides. The fibres 
interlaced themselves loosely to form a network with interstices or spaces between them. The tissue 
was characterized by cellular, fibrous and amorphous components. Collagenic fibres predominated 
and constituted the bulk of the loose connective tissue as shown by Mallory’s tri-chromic staining 
(Fig.6D). Amorphous material was transparent and homogenous under the optical microscope and 
occupied numerous small areas (areolas) in which no structures were orderly seen. 
Class I HLA positive staining (Fig. 6E) clearly demonstrated the human origin of the 
adipose tissue obtained excluding any murine contamination. In addition, the tissue showed a strong 
positivity for adiponectin (Fig. 6F), Glut-4 (Fig. 6G), PPAR-? (Fig. 6H), Collagen Type I (Fig. 6I) 
that are specific markers of both adipose and loose connective tissues. Moreover, the positivity of 
some areas for the endothelial markers such as VEGF, demonstrated that the tissue was well 
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vascularised: in fact, a rich network of blood capillaries in and among the lobules was evidenced 
(Fig. 6J). 
Expression of adipogenic and loose connective differentiation-associated genes 
RT-PCR analyses for adipose differentiation-associated genes in sorted ASCs grown on 
Collagen sponge, after 30 days from implantation, revealed that PPAR-? and adiponectin 
expressions were detectable. Moreover, VEGF levels were highly expressed in all the samples, 
confirming the neo-angiogenesis of the neo-formed adipose tissue. In addition, expression of 
mRNA for fibronectin and collagen type I showed the generation of loose connective tissue 
associated to neo-formed adipose tissue (Fig. 7).   
DISCUSSION
Regenerative medicine and tissue engineering both harness the potency of human cells to 
repair, regenerate, and even recreate tissue and organs with the goal of restoring their architecture 
and functionality. Soft-tissue loss can be caused by trauma, tumour resection, extensive deep burns, 
as well as congenital or acquired anomalies and it presents an ongoing challenge in plastic and 
reconstructive surgery. Standard approaches to soft-tissue reconstruction include autologous tissue 
flaps, autologous fat transplantation and alloplastic implants (Bucky et al., 2008; Megerle et al.,
2011). All of these approaches have disadvantages, including donor-site morbidity, implant 
migration and absorption and foreign body reaction. ASCs are currently used for the engineering of 
substitutes that will ultimately be utilized in several fields of reconstructive surgery. 
The availability of progenitors within the adipose stromal fraction (CD34
+
/CD90
+
 stem 
cells) for building neo-tissue types and the understanding of vectors that govern their differentiation 
emerge as important factors for successful neo-tissue construction. To successfully create a 3D 
structure capable of supporting tissue formation, several key roles of tissue engineering need to be 
considered, including pores with interconnected architecture; material degradability; 
biocompatibility with the seeded cells to enhance cellular activity (O’Brien et al., 2005; Kuberka et
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al., 2002). Therefore, the formation of a new tissue in the 3D matrix structure is highly influenced 
by the chemical composition of the scaffold (Cassel et al., 2001; Liu et al., 2011). The extracellular 
matrix (ECM) is recognized as a highly hydrated network that comprises several main effectors. Its 
architecture provides not only an instructive cue for the conversion and spatial orientation of 
precursor cells (CD34
+
/CD90
+
 stem cells) into a functional tissue but also functional properties 
including osmosis, molecular and nutrient transport. Collagen, being a major protein of the natural 
extracellular matrix (ECM), has been commonly used in the form of a gel for tissue engineering in 
spite of limitations principally related to cell-mediated interactions (Natesan et al., 2010). It is a 
physiological component, with a fast biodegrading rate and a low mechanical strength. In fact, 
many surgeons often add other components to collagen in order to improve its stability (Labbè et
al., 2011). 
Multiple independent groups have examined the surface immunophenotype of ASCs 
isolated from human (Yoshimura et al., 2006; Gronthos et al., 2001; Mitchell et al., 2006). Our 
previous studies have evidenced that adipose tissue houses CD34
+
CD90
+
 multipotent stem cells 
(D’Andrea et al., 2008; De Francesco et al., 2009). No significant difference between subcutaneous 
and omental adipose tissue is demonstrated concerning the expression of these markers. There is 
some controversy in the literature regarding expression of CD34 by ASCs. CD34 is used as marker 
of hematopoietic stem and vascular endothelial cells. Our data suggest that expression of this 
molecule is present in cultured ASCs (De Francesco et al., 2009) but, by contrast, Zuk et al. (2002) 
and De Ugarte et al. (2003), have both reported low-to-absent levels of CD34 expression. In our 
studies, CD34
+
/CD90
+
 stem cells, within human adipose tissue, are numerous. In vitro, this cells are 
able to proliferate and differentiate into mesodermal (such as osteogenic, chondrogenic, adipogenic 
and myogenic) and non mesodermal (such as endothelial cells, epithelial cells) lineages, under 
appropriate stimuli. Moreover, this cells population are capable of differentiating into endothelial 
cells with or without the use of angiogenic factors, then CD34
+
/CD90
+
 stem cells are a endothelial 
commitment (Miranville et al., 2004; De Francesco et al., 2009). 
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On the basis of our in vitro studies of ASCs, tissue regeneration and differentiation 
experiments using CD34
+
/CD90
+
 stem cells with appropriate scaffold have been performed in vivo.
In this study, we describe the in vivo formation of both loose connective and adipose tissues, 
starting from ASCs co-expressing CD34 and CD90 markers and seeded on a biocompatible 
commercial scaffold of type I collagen (Gingistat). This lyophilized collagen sponge is widely used 
as a scaffold for spontaneous bone regeneration, mainly in periodontal diseases. Therefore, its wide 
use reflects the good histo-compatibility of this material with cells. The result of our study suggest 
that ASCs/collagen sponge constructs better support in vivo engraftment, as indicated by 
vascularization after in vivo transplantation. In addition, ASCs/collagen sponge better support 
formation of both loose connective and adipose tissues, as indicated by higher expression levels of 
specific markers. 
Studies by Von Heimburg (2001) have demonstrated that the transplantation of isolated and 
cultured preadipocytes seeded on freeze-dried collagen scaffolds resulted in well-vascularised 
adipose-like tissue. Here, we used CD34
+
/CD90
+
 ASCs demonstrating that these stem cells are 
easily absorbed and distributed among the whole collagen scaffold. The structural characteristics 
and architecture of the collagen sponge with interconnected pores sustained and enhanced both cell 
proliferation and spreading without lose so facility to differentiate. Biodegradable scaffold used in 
the experiments was designed to meet tissue engineering imitating the in vivo three-dimensional 
extracellular architecture and to provide to precursors the signals for develop in desirable 
phenotypes. In the xenograft experiments, analyses of the new-formed tissue through histological 
staining revealed that the collagen, on which CD34
+
/CD90
+
 ASCs were loaded, induced the adipose 
differentiation with complete absorption of scaffold and loose connective tissue, suggesting 
CD34
+
/CD90
+
 ASCs have high affinity for the Type I collagen sponge.  In addition, we found an 
extensive formation of new, tightly integrated vessels throughout the neoformed tissue. By the 
contrast, in xenografts in which non-sorted ASCs were used, only adipose tissue was obtained.
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Investigators have postulated a number of mechanisms through which MSCs can be used to repair 
and regenerate tissues. We may hypothesize that CD34
+
CD90
+
 ASCs may secrete cytokines and 
growth factors that stimulate recovery in a paracrine manner. They could modulate the “stem cell 
niche” of the host by stimulating the recruitment of endogenous stem cells to the site and promoting 
their differentiation along the required lineage pathway (Gimble et al., 2007). In a related manner, 
they might provide antioxidants chemicals, free radical scavengers, and chaperone/heat shock 
proteins at an ischemic site. As a result, toxic substances released into the local environment would 
be removed, thereby promoting recovery of the surviving cells. Exciting studies have suggested that 
transplanted bone marrow–derived MSCs can deliver new mitochondria to damaged cells, thereby 
rescuing aerobic metabolism (Spees et al., 2006). It may develop that similar studies in ASCs will 
uncover a comparable ability to contribute mitochondria. Therefore many and different mechanisms 
highlight the great potentiality of  CD34
+
CD90
+
 ASCs versus unsorted ASCs in transplantations. 
Shape and dimensions are of critical importance to plastic surgery applications of 
engineered soft tissue. Creation and maintenance of the shape and dimensions of the engineered soft 
tissue are perhaps best performance by scaffold biomaterials. Collagen scaffold is biodegradable 
and fully absorbable when transplanted subcutaneously. Moreover, for effective MSC seeding and 
proliferation needed to generate new tissue, the scaffold must be porous and three-dimensional. The 
structure of collagen sponge used in this study confirmed their porous 3D architecture. Pores of the 
collagen matrix have an average size of 300µm. In this study, analysis of CD34
+
/CD90
+
 cells by 
light-inverted microscopy confirmed their satisfactory seeding, proliferation and differentiation 
within pores. 
This is the first time that adipose and loose connective tissues have been obtained, and that a 
complete physiological and functional reconstruction of tissues has been generated reinforcing the 
hypothesis that CD34
+
/CD90
+
 ASCs could be used in regenerative medicine. Moreover, the use of 
the collagen as scaffold with CD34
+
/CD90
+
 ASCs is advantageous for different motivations i. 
commercial available; ii. easily obtainable; iii. avoid donor morbidity; and iv. easily formed into the 
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desired shape and volume. For the repair of tissue defects, especially after cancer ablation, typically 
it is essential to restore both the volume and shape. Therefore, to correct such defects is crucial to 
recreate a three-dimensional multilayer especially for the tissue shape. In an in vivo study of 
engineering adipose tissue using MSC from human bone marrow, Stosich and Mao (2011) have 
used a poly(ethylene glycol) scaffold to maintain a stable shape; instead Lin et al. (2008) have used 
non-biodegradable polyglycolic acid scaffold to keep the predefined shape. Other researchers have 
used natural scaffolds such as fibrin (Mauney et al., 2007) and gelatin sponges (Kimura et al.,
2003). The main drawback of these scaffolds is the fast resorption rate that does not allow the 
achievement of an adequate volume so as not allow the organization of an appropriate shape. 
The novelty of this research is represented by the formation not only of adipose tissue 
starting from ASCs, differently from Von Heimburg (2001) and co-workers who used 
preadipocytes, but also by the formation of loose connective tissue, as shown in this study using 
E&E and Mallory’s trichromic stainings, RT-PCR and immunofluorescence analyses for 
adiponectin, PPAR-?, Glut-4, fibronectin, and collagen I. In particular, we have reconstructed both 
connective and adipose tissues from cultured human ASCs differentiating into adypocytes, 
endoteliocytes, and connective cells, able to secrete cellular matrix components, including collagen 
fibres, fibronectin and amorphous substance. 
In our study, we used a biodegradable and bio-absorbable collagen matrix, so that both the 
volume and the shape of the defect can be reconstructed using a predefined scaffold at the outset. 
The slow biodegradation of the scaffold allows maintenance of the scaffold volume of adipose 
tissue newly generated by SVF. 
On the basis of both in vitro and in vivo experiments and on the basis of preclinical studies 
available in the literature (Mizuno, 2009), ASCs/collagen construct could be applied to various 
clinical fields, such as treatment of chronic ulcers, cancer ablation, post-traumatic calvarial bone 
defect, but also could be an alternative to soft tissue augmentation surgery including cosmetic breast 
augmentation.  
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In conclusion, with this study we provided evidence that ASCs differentiate in vivo into both 
adipose and loose connective tissues, when loaded on collagen scaffold. This demonstrates the 
feasibility of collagen scaffold with sorted ASCs (CD34
+
/CD90
+
) as transplantation vehicle for 
adipose and loose connective tissue engineering and its employment for reconstruction in plastic 
and reconstructive surgery. Collagen scaffolds were demonstrated to be suitable materials for soft-
tissue regeneration; they maintained volume when seeded with sorted ASCs. The material had a 
progressive rate of biodegradation, lacked cytotoxicity and did not induce a systemic immune 
response or chronic inflammation in this human in vivo model. The observed tissue integration is 
promising and in addition of this the angiogenic formation suggest that collagen scaffold would be 
an efficient biomaterial for adipose and loose connective growth and function. 
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FIGURE LEGENDS
Fig 1. Representative image of flow cytometric analyses performed at day 0, 15, and 30 of culture. 
(A,B) At day 0, a significant percentage of ASCs are clearly positive for stromal markers, including 
CD117 (5%), CD34 (7%); for mesenchymal markers, including CD29 (72%), CD105 (5%), CD34 
(25%), CD90 (30%) and for endothelial markers, including CD31 (6%), CD133 (8%), CD44/CD54 
(5%), and Flk-1 (45%); (C) Sorting image for CD34
+
CD90
+
; (D) At day 15 co-expression of CD34 
and CD90 markers was 80%; (E) After 30 days of culture, co-expression of CD34 and CD90 was 
8%, while only CD90 expression was 80%. 
Fig 2. Representative image showing growth curves of CD34+/CD90+ cells with respect to CD34-
/CD90
-
 and unsorted cells displaying a different mean doubling time. 
Fig 3. Image showing (A) unsorted cells in adipogenic medium, exhibiting the morphology of 
fibroblasts (arrowheads), whereas other cells exhibiting the morphology of multi-vacuolar 
adipocytes (arrows) (Scale bar: 150 µm); (B) some unsorted cells in adipogenic medium, displaying 
positivity for adiponectin by immunohistochemistry (Scale bar: 150 µm); (C) CD34
+
/CD90
+
 ASCs 
in adipogenic medium, exhibiting the characterictic adipocyte morphology (Scale bar: 250µm); (D) 
CD34
+
/CD90
+
 ASCs in adipogenic medium, displaying positivity for adiponectin by 
immunohistochemistry (Scale bar: 250µm); (E) CD34
+
/CD90
+
 ASCs in adipogenic medium, 
showing positivity for PPAR-? by immunohistochemistry (Scale bar: 150µm). (F) differentiated 
endothelial cells that, after day 7 of culture in presence of methylcellulose, formed a rather extended 
intercellular tube network (Scale bar: 250µm); (G) flow cytometry demonstrating that a significant 
number of ASCs are positive for endothelial markers, including CD90 (97%), CD44 (90%), CD54 
(90%), VEGF (70%), CD133 (18%), and Flk-1 (60%). Control FITC-conjugated and PE-conjugated 
isotypes were in green.
Fig. 4. Figure showing the viability of sorted ASCs in (A) controls (Scale bar: 100µm) and (B) 
when loaded onto the scaffold (Scale bar: 100µm). In both cases Calcein staining demonstrates a 
high viability, also after adherence to the scaffold in (B). In order to evaluate cell proliferation, 
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constructs were analyzed by inverted microscope after 7 (C) and 14 day (D) and by histology after 7 
(E) and 14 day (F) (Scale bar: 250µm). Light-inverted microscopy and H&E staining on serial 
sections of ASCs seeded onto the Gingistat collagen sponge demonstrated that the cells were 
homogeneously distributed throughout the whole sponge. Moreover, at day 14, either a strong 
spreading or ASCs proliferation was observed with respect to day 7 (arrowheads indicate the 
scaffold and the arrows indicate the cells).
Fig. 5. Figure showing in (A) sorted ASCs/collagen construct before implantation; (B) sorted 
ASCs/collagen construct injected into nude mice and withdrawn after 30 days of implantation;(C) 
sorted ASCs/Collagen construct explanted from a nude mouse; (D) Collagen scaffold, grafted 
without cells (used as control) which was not detectable on the dorsum of mice, because completely 
reabsorbed.
Fig. 6. Figure showing: (A) H&E stain displaying that, within the unsorted ASCs/collagen 
constructs, stem cells only differentiated towards adipocytes (arrowheads indicate the scaffold and 
the arrows indicate the adipocytes) (Scale bar: 150µm); (B) H&E staining displaying that, within 
the sorted ASCs/collagen constructs, stem cells differentiated towards adipocytes (Scale bar 
250µm); (C) H&E staining shows that fat cell are often surrounded by a network of loose 
connective tissue (Scale bar 250µm); (D) Collagenous fibres predominated and constituted the bulk 
of the loose connective tissue (Mallory’s Trichrome staining) (Scale bar: 250µm); (E) Class I HLA 
positive staining clearly demonstrated the human origin of the adipose tissue obtained excluding 
any murine contamination (Scale bar 100µm); (F) Immunofluorescence staining for adiponectin 
(Scale bar 100µm); (G) Immunofluorescence staining for Glut-4 (Scale bar: 100µm); (H) 
Immunofluorescence staining for PPAR-? (Scale bar: 250µm); (I) Immunofluorescence staining for 
Collagen Type I (Scale bar 250µm); (J) Immunofluorescence staining for VEGF (arrowheads
indicate the capillary-like cells network). (Scale bar: 250µm); 
Fig. 7. RT-PCR analyses. Figure showing adipose differentiation-associated genes in sorted ASCs 
grown on collagen sponge, after 30 days from implantation. Analyses revealed that PPAR-? and 
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adiponectin expressions as well as VEGF were highly expressed, confirming the adipose tissue 
formation with neo-angiogenesis. 
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Table 1. In vivo construct implantation protocol 
Right side Left side Scaffold size Cell number 
Nude mouse 1 unsorted ASCs/Collagen ASCs CD34
+
CD90
+
/Collagen 10x10 mm  2x10
5
 cells 
Nude mouse 2 unsorted ASCs/Collagen ASCs CD34
+
CD90
+
/Collagen 10x10 mm  2x10
5
cells
Nude mouse 3  unsorted ASCs/Collagen ASCs CD34
+
CD90
+
/Collagen 10x10 mm  2x10
5
cells
Nude mouse 4  unsorted ASCs/Collagen ASCs CD34
+
CD90
+
/Collagen 10x10 mm  2x10
5
cells
Nude mouse 5  unsorted ASCs/Collagen ASCs CD34
+
CD90
+
/Collagen 10x10 mm  2x10
5
cells
Nude mouse 6  unsorted ASCs ASCs CD34
+
CD90
+
0 2x10
5
cells
Nude mouse 7  unsorted ASCs ASCs CD34
+
CD90
+
0 2x10
5
cells
Nude mouse 8 Collagen Collagen 10x10 mm  0
Nude mouse 9 Collagen Collagen 10x10 mm  0
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Table 2. The in vivo construct explantation 
Right side Tissue volume (mm3) New tissue formed Left side Tissue volume (mm3) New tissue formed 
Nude mouse 1  unsorted ASCs/Collagen 85.2 ± 1,1 Adipose tissue ASCs CD34+CD90+/Collagen 152.3 ± 1,4 Adipose and loose connective  
Nude mouse 2  unsorted ASCs/Collagen 129 ± 0,8 Adipose tissue ASCs CD34+CD90+/Collagen 102.5 ± 0,6 Adipose and loose connective 
Nude mouse 3  unsorted ASCs/Collagen 135 ± 1,5 Adipose tissue ASCs CD34+CD90+/Collagen 95.6 ± 1,1 Adipose and loose connective 
Nude mouse 4  unsorted ASCs/Collagen 100.8 ± 0,3 Adipose tissue ASCs CD34+CD90+/Collagen 132.8 ± 0,8 Adipose and loose connective 
Nude mouse 5  unsorted ASCs/Collagen 147.6 ± 0,5 Adipose tissue ASCs CD34+CD90+/Collagen 146.5 ± 1,2 Adipose and loose connective 
Nude mouse 6  unsorted ASCs reabsorbed reabsorbed ASCs CD34+CD90+ reabsorbed reabsorbed
Nude mouse 7  unsorted ASCs reabsorbed reabsorbed ASCs CD34+CD90+ reabsorbed reabsorbed
Nude mouse 8 Collagen reabsorbed  reabsorbed Collagen reabsorbed reabsorbed
Nude mouse 9 Collagen reabsorbed  reabsorbed Collagen reabsorbed reabsorbed
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